Insider Transactions in Q2 2025 at Roivant Sciences Ltd. (ROIV)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2025
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,653
-0.41%
|
$18,183
$11.39 P/Share
|
|
Jun 25
2025
|
Qvt Financial LP |
SELL
Other acquisition or disposition
|
Indirect |
36,756,758
-66.47%
|
-
|
|
Jun 25
2025
|
Keith S Manchester |
SELL
Other acquisition or disposition
|
Indirect |
17,389,525
-49.71%
|
-
|
|
Jun 25
2025
|
Daniel Allen Gold |
SELL
Other acquisition or disposition
|
Indirect |
36,756,758
-66.47%
|
-
|
|
Jun 20
2025
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
100,000
-6.4%
|
$1,100,000
$11.45 P/Share
|
|
Jun 20
2025
|
Eric Venker President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+6.02%
|
$300,000
$3.85 P/Share
|
|
Jun 20
2025
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,503
-0.38%
|
$16,533
$11.45 P/Share
|
|
Jun 20
2025
|
Vivek Ramaswamy > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
577,007
-1.52%
|
$6,347,077
$11.46 P/Share
|
|
Jun 18
2025
|
Vivek Ramaswamy > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
565,266
-1.47%
|
$6,217,926
$11.45 P/Share
|
|
Jun 06
2025
|
Vivek Ramaswamy > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
200,800
-0.52%
|
$2,208,800
$11.19 P/Share
|
|
Jun 04
2025
|
Vivek Ramaswamy > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
547,430
-1.4%
|
$6,021,730
$11.34 P/Share
|
|
Jun 03
2025
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
566,278
-27.92%
|
$6,229,058
$11.22 P/Share
|
|
Jun 03
2025
|
Eric Venker President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
785,026
+27.9%
|
$2,355,078
$3.85 P/Share
|
|
Jun 02
2025
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
433,722
-25.86%
|
$4,770,942
$11.07 P/Share
|
|
Jun 02
2025
|
Eric Venker President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
600,000
+26.35%
|
$1,800,000
$3.85 P/Share
|
|
May 28
2025
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,653
-0.41%
|
$16,530
$10.62 P/Share
|
|
May 20
2025
|
Matthew Gline CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,945
-0.06%
|
$120,395
$11.04 P/Share
|
|
May 20
2025
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
100,000
-8.49%
|
$1,000,000
$10.95 P/Share
|
|
May 20
2025
|
Eric Venker President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+7.83%
|
$300,000
$3.85 P/Share
|
|
May 20
2025
|
Eric Venker President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
39,148
-3.51%
|
$430,628
$11.04 P/Share
|
|
May 20
2025
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,487
-0.86%
|
$38,357
$11.04 P/Share
|
|
May 07
2025
|
Vivek Ramaswamy > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
625,000
-1.57%
|
$6,875,000
$11.18 P/Share
|
|
May 06
2025
|
Vivek Ramaswamy > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
273,959
-0.68%
|
$3,013,549
$11.47 P/Share
|
|
Apr 28
2025
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,653
-0.41%
|
$18,183
$11.19 P/Share
|
|
Apr 21
2025
|
Richard Pulik CFO |
BUY
Grant, award, or other acquisition
|
Direct |
141,464
+25.78%
|
-
|
|
Apr 21
2025
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
100,000
-8.22%
|
$1,000,000
$10.22 P/Share
|
|
Apr 21
2025
|
Eric Venker President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+7.6%
|
$300,000
$3.85 P/Share
|
|
Apr 20
2025
|
Matthew Gline CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,945
-0.06%
|
$109,450
$10.15 P/Share
|
|
Apr 20
2025
|
Eric Venker President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,945
-0.97%
|
$109,450
$10.15 P/Share
|
|
Apr 17
2025
|
Ilan Oren |
SELL
Payment of exercise price or tax liability
|
Direct |
64
-0.06%
|
$640
$10.15 P/Share
|
|
Apr 17
2025
|
Ilan Oren |
BUY
Grant, award, or other acquisition
|
Direct |
2,635
+2.5%
|
-
|
|
Apr 17
2025
|
James C Momtazee |
SELL
Payment of exercise price or tax liability
|
Direct |
276
-0.29%
|
$2,760
$10.15 P/Share
|
|
Apr 17
2025
|
James C Momtazee |
BUY
Grant, award, or other acquisition
|
Direct |
1,379
+1.42%
|
-
|
|
Apr 17
2025
|
Epperly Melissa B, |
BUY
Grant, award, or other acquisition
|
Direct |
1,847
+4.27%
|
-
|